The Indian pharma sector showed mixed to negative performance on January 29, 2026, as of 10:18 AM IST, amid broader market declines. The sector largely underperformed benchmarks, with most listed stocks trading in the red.
The S&P BSE Healthcare index stood at 40,812.57, down 1.08%. Broader indices also declined: S&P BSE Sensex at 81,767.69 (-0.70%) and Nifty 50 at 25,211.65 (-0.52%).
Individual pharma stocks reflected this trend, with declines in major names dominating early trade:
- Aarti Drugs: BSE 377.10 (-1.98%), NSE 377.55 (-1.86%)
- Ajanta Pharma: BSE 2,700.65 (-0.61%), NSE 2,701.20 (-0.63%)
- Alembic Pharma: BSE 759.50 (-0.70%), NSE 757.90 (-0.76%)
- Aurobindo Pharma: BSE 1,128.90 (-0.99%), NSE 1,129.10 (-0.95%)
- Biocon: BSE 362.00 (-2.20%), NSE 361.60 (-2.40%)
- Cipla: BSE 1,308.45 (-1.49%), NSE 1,308.90 (-1.47%)
- Divis Laboratories: BSE 6,108.20 (-1.53%), NSE 6,112.50 (-1.22%)
- Dr. Reddy’s Lab: BSE 1,192.25 (-2.62%), NSE 1,192.60 (-2.45%)
- Glenmark Pharma: BSE 1,985.60 (-0.36%), NSE 1,983.80 (-0.49%)
- Indoco Remedies: BSE 215.45 (-0.46%), NSE 215.24 (-0.67%)
- Ipca Labs: BSE 1,451.35 (+0.24%), NSE 1,454.00 (+0.48%)
- J.B. Chemicals: BSE 1,851.50 (-0.17%), NSE 1,850.40 (-0.32%)
- Lupin: BSE 2,100.20 (-1.01%), NSE 2,097.90 (-1.48%)
- Mankind Pharma: BSE 2,103.75 (-0.56%), NSE 2,105.70 (-0.53%)
- Natco Pharma: BSE 814.30 (-0.59%), NSE 813.80 (-0.57%)
- Orchid Pharma: BSE 692.60 (-0.40%), NSE 691.15 (-0.97%)
- Panacea Biotec: BSE 360.90 (-3.11%), NSE 361.65 (-3.12%)
- Strides Pharma Science: BSE 804.60 (+1.06%), NSE 803.55 (+0.92%)
- Sudeep Pharma Ltd.: BSE 590.50 (+0.79%), NSE 602.85 (+2.69%)
- Sun Pharma: BSE 1,587.65 (-1.40%), NSE 1,587.80 (-1.42%)
- Torrent Pharma: BSE 3,933.90 (-0.56%), NSE 3,933.20 (-0.64%)
- Wockhardt: BSE 1,360.00 (+0.22%), NSE 1,358.50 (+0.13%)
- Zydus Lifesciences: BSE 884.60 (-1.34%), NSE 884.00 (-1.44%)
Notable gainers included Strides Pharma Science, Sudeep Pharma, Ipca Labs, and Wockhardt, while steeper losses appeared in Panacea Biotec, Dr. Reddy’s Lab, and Biocon.
Prices are subject to change as the session progresses. For real-time updates, refer to NSE/BSE platforms.